Jentadueto XR 1000 mg/1

Jentadueto XR 1000 mg/1 combines linagliptin and metformin hydrochloride for extended-release oral administration. This medication is designed to support blood sugar management in adults with type 2 diabetes. Learn more about its uses and effects.

Jentadueto XR 1000 mg/1 is primarily used to help manage blood sugar levels in adults with type 2 diabetes. It combines two active ingredients, linagliptin and metformin hydrochloride, to work together in supporting glucose control. This medication is often prescribed as part of a comprehensive diabetes management plan, which may include diet and exercise.

Common effects of Jentadueto XR 1000 mg/1 may include gastrointestinal discomfort, such as diarrhea or nausea, particularly when first starting the medication. Some users may also experience headache or low blood sugar, especially when combined with other diabetes medications. These effects can vary from person to person.

Jentadueto XR 1000 mg/1 should be handled with care, especially for those with kidney issues or a history of lactic acidosis. It is important to follow the prescribed dosage and administration instructions provided by a healthcare professional. Always inform your healthcare provider about any other medications you are taking to avoid potential interactions.

Jentadueto XR 1000 mg/1 may interact with certain medications, including other diabetes drugs, diuretics, and some antibiotics. Alcohol consumption should be avoided as it can increase the risk of lactic acidosis. Always consult a healthcare professional before starting or stopping any medication.